Vineet Laboratories Limited has informed the Exchange about the increase of Authorised Share Capital of the Company and the consequent alteration of Clause V of the Memorandum of Association of the Company, subject to the approval of the shareholders
VINEETLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Vineet Laboratories Limited, at its meeting on May 14, 2025, approved two key items, both subject to shareholder approval. First, the company will increase its Authorised Share Capital from ₹10.81 crore (1,08,10,000 equity shares of ₹10 each) to ₹20 crore (2,00,00,000 equity shares of ₹10 each), nearly doubling the authorised limit, and will alter Clause V of its Memorandum of Association accordingly. Second, Mr. Rajesh Kumar Kathulla (DIN: 05349717) has been appointed as Additional Director designated as Whole Time Director for a three-year term from May 14, 2025 to May 13, 2028. Mr. Kathulla is a B.Tech (Computer Science) with over 10 years of experience in administration, finance, and business management, and holds 49,907 equity shares in the company. He has no relationship with any existing directors and has not been debarred by SEBI from holding a directorship.
The hike in Authorised Share Capital gives the company room to raise additional funds or issue bonus shares in the future, but does not mean any new shares are being issued right now. The new Whole Time Director appointment brings in operational and finance expertise, which could support future growth. Shareholders should watch for the postal ballot or EGM notice seeking their approval for these items.